US law firm Covington & Burling has advised on the creation of a joint venture that will help to develop a vaccine that could become the first new vaccine licensed to prevent tuberculosis in 80 years. Covington advised regular client Emergent BioSolutions on the venture with the University of Oxford to develop the MVA85A vaccine, which is thought to be the most clinically advanced of its kind.
August 27, 2008 at 08:17 AM
1 minute read
The original version of this story was published on Legalweek
US law firm Covington & Burling has advised on the creation of a joint venture that will help to develop a vaccine that could become the first new vaccine licensed to prevent tuberculosis in 80 years.
Covington advised regular client Emergent BioSolutions on the venture with the University of Oxford to develop the MVA85A vaccine, which is thought to be the most clinically advanced of its kind.
Presented by BigVoodoo
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The African Legal Awards recognise exceptional achievement within Africa s legal community during a period of rapid change.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Lower Manhattan firm seeks a premises liability litigator (i.e., depositions, SJ motions, and/or trials) with at least 3-6 years of experien...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
